Churchill Capital Corp XII Units

CXIIU

New York, NY, June 15, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XII (Nasdaq: CXIIU) (the “Company”) announced today that, commencing June 17, 2026, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Street research is expected for one company, and lock-up periods will be expiring for six companies.